A theme involving growth in cases of cardiovascular disease and demand for cardiovascular treatments and related products, including atrial fibrillation ablation, driven by population ageing and an increase in the number of cardiovascular disease cases. It also encompasses a market structure in which pressure to reduce prices due to healthcare cost containment persists.